BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 194 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,409,040 | -19.9% | 199,017 | -20.4% | 0.00% | -20.0% |
| Q2 2023 | $1,759,169 | -11.9% | 249,882 | +4.3% | 0.01% | -16.7% |
| Q1 2023 | $1,997,263 | -6.8% | 239,480 | +28.3% | 0.01% | -14.3% |
| Q4 2022 | $2,141,996 | -10.0% | 186,585 | -1.2% | 0.01% | -12.5% |
| Q3 2022 | $2,380,000 | +14.8% | 188,902 | -3.6% | 0.01% | +60.0% |
| Q2 2022 | $2,073,000 | -46.4% | 195,900 | -17.6% | 0.01% | -37.5% |
| Q1 2022 | $3,867,000 | +7.5% | 237,800 | -8.4% | 0.01% | +14.3% |
| Q4 2021 | $3,597,000 | -3.6% | 259,700 | 0.0% | 0.01% | -12.5% |
| Q3 2021 | $3,732,000 | -9.1% | 259,700 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $4,106,000 | +50.1% | 259,700 | -3.4% | 0.01% | +33.3% |
| Q1 2021 | $2,735,000 | +25.7% | 268,900 | -7.9% | 0.01% | +20.0% |
| Q4 2020 | $2,175,000 | +85.7% | 292,000 | -14.3% | 0.01% | +66.7% |
| Q3 2020 | $1,171,000 | +6.5% | 340,900 | +47.7% | 0.00% | 0.0% |
| Q2 2020 | $1,100,000 | +140.7% | 230,800 | +1.0% | 0.00% | +50.0% |
| Q1 2020 | $457,000 | -19.8% | 228,600 | +38.5% | 0.00% | +100.0% |
| Q4 2019 | $570,000 | +20.5% | 165,100 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $473,000 | -18.2% | 165,100 | +8.2% | 0.00% | -50.0% |
| Q2 2019 | $578,000 | -52.4% | 152,600 | +2.3% | 0.00% | -33.3% |
| Q1 2019 | $1,214,000 | +33.7% | 149,200 | +32.6% | 0.00% | 0.0% |
| Q4 2018 | $908,000 | +18.7% | 112,500 | +12.2% | 0.00% | +50.0% |
| Q3 2018 | $765,000 | +33.0% | 100,300 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $575,000 | +115.4% | 100,300 | +79.1% | 0.00% | +100.0% |
| Q1 2018 | $267,000 | -2.9% | 56,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $275,000 | -6.1% | 56,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $293,000 | -5.8% | 56,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $311,000 | – | 56,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |